1 2 4 5 12 36 41 49 69 76 77 78 80 81 83 178

15 13 77 9 Estera Trust (Cayman) Ltd. Clifton House, 75 Fort Street PO Box 1350 Grand Cayman KY1-1108 Cayman Islands 198 A 8-9 6-8 19 1906-1907 Estera Trust (Cayman) Ltd. Clifton House 75 Fort Street PO Box 1350 Grand Cayman KY1-1108 Cayman Islands 2

98 359-361 1 2 183 22 01110 www.kingworld.com.cn 3 2017

1,031,488 1,053,527 (2.1)% (708,317) (729,955) (3.0)% 323,171 323,572 (0.1)% 83,327 89,044 (6.4)% 66,532 67,406 (1.3)% 51,060 46,966 8.7% 8.20 7.26 12.9% 3.43 2.95 16.3% (1) 1.26 1.22 (2) 1.03 1.05 (3), 31.0 22.3% 8.7 (1) (2) (3) 100% 4

80 (GDP) 6.9% GDP GDP 6.5% 6.8% 9.5% 13,329 5 2017

(CFDA) 55.8% 23.9% 20.3% 1. 32 70 6

8.4% 78,847,000 2. 2,300 2030 (Culturelle) 18.1% 2.8 Lifeline Care Lifeline Care 2.7 Tilman Zuccari 100% 7 2017

3. 4,480 2,690 72.70% 1,010 27.30% 1. OTC 200,000 OTC 1,500 34 24 17 341 8

2. Hybris 3. 5,400,000 4. 5,000 9 2017

1. KPI KCI 2. Medical Insight 60.3% 10.7% 32.2% 3. OMO 187 8 17.3% 7.7% OMO 10

4. 11 2017

1. (GDP) 6.5% GDP 6.9% 18,322 7.1% 6.0% 2. 19 12

2030 8 16 31,195 11,422 (CAGR) 9.4% 13.1% 1,305.6 753.9 10.6% 23.3% 3. 159.06 1932.20 34.53% 24 (Culturelle) 210,336,000 32.0% 4. 1,786 9.17% 2.8 Lifeline Care Lifeline Care 2.7 (i) (ii) (iii) 13 2017

HP0 5. 6.7 24.1% CAGR 33.6% 15.7% 12 (Culturelle) Lifeline Care 1,031,488,000 55.8% 575,322,000 10.7% 23.9% 246,803,000 10.9% 20.3% 209,363,000 11.9% 14

(1) 15 2017

(i) (ii) (iii) (iv) 32 70 542,589,000 13.6% 34,404,000 1.7% (2) 8.4% 78,847,000 16

17 2017

(3) 17 18

(2013-2017) (1) (Culturelle) 210,336,000 32.0% 19 2017

30 35 220 30,000+ AEON (2) Lifeline Care Lifeline Care 20

SEO 2.7 (3) 14 23 10% Tilman Zuccari 100% Kissbaby 4,480 30% 19.9% 15% 20% 55% 21 2017

1. KPI KCI 2. OTC 200,000 4,000 34 24 17 341 1,000 200 400 800 OTC 100 30 1,500 22

3. SAP Hybris Lifeline Care 23 2017

4. 5,400,000 3,500,000 24

5,000 (SIDS) (SIDA) (Silver Award) (OA) 72 5. 6. 50,000,000 15% 8.6 (02289.HK) 2,302,000 25 2017

90% 2017 2019 Lifeline Care 2016 2016 AAA 2015 2017 TOP10 2017 2017 26

27 2017

1. 1,031,488,000 1,053,527,000 22,039,000 2.1% 2. 708,317,000 729,955,000 21,638,000 3.0% 30.7% 31.3% 3. 38,311,000 15,401,000 22,910,000 10,516,000 18,458,000 7,769,000 4. 162,105,000 149,129,000 12,976,000 8.7% 4,215,000 1,190,000 3,721,000 803,000 5. 89,313,000 75,543,000 13,770,000 18.2% 3,144,000 17,865,000 3,893,000 12,828,000 3,665,000 10,380,000 5,759,000 7,813,000 6. 95,703,000 95,720,000 17,000 0.0% 28

7. 26,210,000 12,969,000 13,241,000 102.1% 8. 83,327,000 89,044,000 5,717,000 6.4% 13,241,000 7,541,000 9. 16,795,000 21,638,000 4,843,000 22.4% 20.2% 24.3% 10. 51,060,000 46,966,000 4,094,000 8.7% 4,968,000 874,000 1. 2. 412,874,000 437,874,000 25,000,000 35,246,000 148,881,000 127,633,000 21,248,000 16,482,000 3. (a) 92,198,000 29 2017

(b) 57,483,000 22,808,000 34,675,000 5,579,000 4. 242,114,000 271,689,000 29,575,000 110,810,000 81,235,000 1. 72,388,000 3,751,000 2. 4,029,000 17,810,000 3. 62,970,000 121,052,000 30

1. 412,980,000 311,196,000 2. 31.0% 22.3% 100% 3. 100,000,000 61,017,000 23,168,000 96,000,000 3.30% 5.66% 232,755,000 229,984,000 168,793,000 30,661,000 4. 40,125,000 11,380,000 31 2017

(1) 15% (2) (3) 2,900 1. LifeLine Care 32

3. 2. ODM 33 2017

4. OMO OMO 5. 6. GMP 34

998 130 392 34 476 118,689,000 84,446,000 EMBA EDP 3.43 21,352,000 35% 35 2017

59 22 Business Management Qualification Accreditation Committee 54 21 12 EMBA 36

51 20 52 27 000607 600976 600422 600572 000650 37 2017

49 22 Victoria University of Technology Going Accounting Services Company 2389 1803 57 25 38

57 32 52 27 59 15 47 19 49 27 012 53 17 39 2017

55 24 55 22 23 1,000,000 40

A.2.1 A.2.1 41 2017

3.10(1) (2) 3.10A 42

D.3.1 B.1.2(c)(ii) 43 2017

44

4/4 1/1 4/4 1/1 4/4 1/1 4/4 1/1 4/4 2/2 2/2 2/2 1/1 4/4 2/2 2/2 2/2 1/1 4/4 2/2 2/2 2/2 1/1 A.6.5 45 2017

1,435,000 1,658,000 409,000 473,000 46

3.29 47 2017

6-8 19 1906-1907 kingw@kingworld.com.cn www.kingworld.com.cn 48

(i) (ii) 76 177 3.43 21,352,000 35% 183 22 183 22 49 2017

12 35 178 3R (Reduce) (Recycle) (Reuse) 50

32 51 2017

241,862,000 206,167,000 136,920,000 6,000,000 15,760,000 20,600,000 94,560,000 (a) 10% 600,000,000 30% 60,000,000 10% 9.64% (b) (c) (d) (e) 1% (i) (ii) (iii) 10 1 52

(f) (g) 1 2 6 3 4 2.54 520,000 (156,000) 364,000 0.06% 2.54 468,000 (140,000) 328,000 0.05% 2.54 468,000 (140,000) 328,000 0.05% 2.54 412,000 (124,000) 288,000 0.05% 2.54 412,000 (124,000) 288,000 0.05% 2.54 412,000 (124,000) 288,000 0.05% 2.54 412,000 (412,000) 0.00% 3,104,000 (1,220,000) 1,884,000 0.30% 57 2.54 13,236,000 (4,971,000) 8,265,000 1.33% 5 5 16,340,000 (6,191,000) 10,149,000 1.63% 2.54 300,000 (300,000) 0.00% 2.54 6,200,000 6,200,000 0.99% 22,840,000 (6,491,000) 16,349,000 2.63% 1 2 53 2017

3 4 5 6 2.45 (i) 30,000 (ii) 6,200,000 2.54 27 25% 54

31 80 31 109,238,000 168,527,000 3.43 2.87 2.95 2.64 17,866,000 16,434,000 5,400,000 7,205,000 13 4,470,000 14 55 2017

17 36 40 3.13 11 56

11 1,518 1,286 1,876 176,400 57 2017

359 359 359 58

(a) XV (i) XV 7 8 (ii) 352 (iii) (I) 1 11,220,000 1.80% 90,000,000 14.46% 297,812,250 47.84% 2 309,032,250 49.64% 90,000,000 14.46% 3 3,800,000 0.61% 1. 11,220,000 387,812,250 (a) 297,812,250 297,812,250 (b) 90,000,000 90,000,000 2. 399,032,250 (a) 90,000,000 90,000,000 (b) 11,220,000 297,812,250 11,220,000 297,812,250 3. 3,800,000 59 2017

(II) 3 4 1 2 2.54 520,000 (156,000) 364,000 0.06% 2.54 468,000 (140,000) 328,000 0.05% 2.54 468,000 (140,000) 328,000 0.05% 2.54 412,000 (124,000) 288,000 0.05% 2.54 412,000 (124,000) 288,000 0.05% 2.54 412,000 (124,000) 288,000 0.05% 2,692,000 (808,000) 1,884,000 0.30% 1 2 3 4 2.45 60

(III) 100% 100% XV (i) XV 7 8 (ii) 352 (iii) XV 2 3 61 2017

(b) XV 2 3 336 297,812,250 47.84% 90,000,000 14.46% 1 11,220,000 1.80% 90,000,000 14.46% 297,812,250 47.84% 2 309,032,250 49.64% 90,000,000 14.46% Sinopharm Healthcare Fund L.P. 3 62,187,750 9.99% Sinopharm Capital Limited 4 62,187,750 9.99% Sun Hill Capital Investments Limited 5 62,187,750 9.99% 6 62,187,750 9.99% 62

1. 11,220,000 387,812,250 (a) 297,812,250 297,812,250 (b) 90,000,000 90,000,000 2. 399,032,250 (a) 90,000,000 90,000,000 (b) 11,220,000 297,812,250 11,220,000 297,812,250 3. Sinopharm Healthcare Fund L.P. 133,703,662.5 62,187,750 4. Sinopharm Capital Limited Sinopharm Healthcare Fund L.P. 1.91% 5. Sun Hill Capital Investments Limited Sinopharm Capital Limited 100% Sinopharm Healthcare Fund L.P. 1.91% Shine Light Fund Management Limited 100% Shine Light Investment Fund 0.11% 6. Sun Hill Capital Investments Limited 70% Sinopharm Capital Limited 100% Sinopharm Healthcare Fund L.P. 1.91% Shine Light Fund Management Limited 100% Shine Light Investment Fund 0.11% XV 2 3 336 63 2017

64

14A 36 14A 36 12 14A 14A 9,187 24,340 3,174 5,468 65 2017

51% 49% 40% 51% 49% 40% 66

(i) (ii) (iii) (i) (ii) (iii) (iv) 100,000,000 61,017,000 23,168,000 96,000,000 3.30% 5.66% 232,755,000 229,984,000 67 2017

11.3% 2.6% 66.7% 55.5% 5% 2(w) 68

76 177 69 2017

a 2(j)(ii) 18 20 33(b) (i) 90,693,000 78,503,000 18 20 70

(b) 2(e) (j)(i) 21 24 32(f) 33(h) 39,924,000 22,670,000 21 24 32(f) 71 2017

(c) 2(j)(i) 23 32(a) (iii) 33(d)) 254,547,000 5,440,000 90 31.61% 23 32(a) (iii) 72

405 73 2017

74

P04963 75 2017

4 1,031,488 1,053,527 (708,317) (729,955) 323,171 323,572 14 4,470 250 6 38,311 15,401 (162,105) (149,129) (89,313) (75,543) 20 (18,831) (18,831) 95,703 95,720 7(a) (26,210) (12,969) 13,834 6,239 7 83,327 89,044 8 (16,795) (21,638) 66,532 67,406 51,060 46,966 15,472 20,440 66,532 67,406 10 8.20 7.26 8.20 7.26 83 177 76

66,532 67,406 1,561 (4,599) 615 7,969 (5,241) (2,395) (3,065) 975 63,467 68,381 48,273 48,705 15,194 19,676 63,467 68,381 83 177 77 2017

13 92,198 13 57,483 22,808 14 112,600 108,130 19 43,067 69,233 15 75,000 16 18,988 18 90,693 90,693 20 78,503 97,334 24 4,775 4,232 21 14,141 19,401 493,460 505,819 22 148,881 127,633 23 412,874 437,874 21 25,783 65,199 30 533 24 17,895 17,400 25 750 9,297 25 232,755 229,984 838,938 887,920 26 242,114 271,689 30 13,623 27 412,980 311,196 28 114,909 29(a) 10,028 15,503 665,122 726,920 173,816 161,000 667,276 666,819 29(b) 25,641 28,169 25,641 28,169 641,635 638,650 83 177 78

31 53,468 53,468 499,626 470,347 553,094 523,815 17 88,541 114,835 641,635 638,650 83 177 79 2017

31(a)) 31(b)) 31(c)) 31(d)) 31(e)) 31(f)) 31(g)) 31(h)) 31(i)) 53,468 152,700 38,740 29,068 6,259 6,773 (20,678) 753 (19,654) 276,386 523,815 114,835 638,650 51,060 51,060 15,472 66,532 1,561 1,561 1,561 579 579 36 615 (4,927) (4,927) (314) (5,241) (4,348) 1,561 (2,787) (278) (3,065) (4,348) 1,561 51,060 48,273 15,194 63,467 5,368 (5,368) 9(b)) (15,350) (15,350) (15,350) 17(e)) (52,488) (52,488) 17(f)) (11,000) (11,000) 11,000 28) (6,259) 19,654 (13,395) 7,356 7,356 7,356 53,468 152,700 44,108 29,068 2,425 (19,117) 8,109 282,333 553,094 88,541 641,635 53,468 152,700 34,157 29,068 94,905 435 (16,079) 210 242,522 591,386 95,880 687,266 46,966 46,966 20,440 67,406 (4,599) (4,599) (4,599) 7,655 7,655 314 7,969 (1,317) (1,317) (1,078) (2,395) 6,338 (4,599) 1,739 (764) 975 6,338 (4,599) 46,966 48,705 19,676 68,381 4,583 (4,583) 9(b)) (8,519) (8,519) (8,519) 17(e)) (721) (721) 543 543 543 28 (88,646) (19,654) (108,300) (108,300) 53,468 152,700 38,740 29,068 6,259 6,773 (20,678) 753 (19,654) 276,386 523,815 114,835 638,650 83 177 80

83,327 89,044 7(c) 5,579 4,234 7(c) 1,365 7(a) 26,210 12,969 6 (633) (597) 6 (1,483) (1,705) 6 (623) (365) 6 (1,849) (2,439) 7(c) 119 153 7(c) 7,614 526 7(c) 330 7(c) (237) 951 7(c) 4,897 7(c) (3,717) 7(c) (1,282) 7(c) 248 6 (2,236) (1,566) 6 4,071 6 (13,255) (2,739) 7(c) 18,831 18,831 (13,834) (6,293) 14 (4,470) (250) 22 3,096 (19,966) (51,724) 44,789 (148,326) 8,547 (1,597) (39,575) 104,943 97,186 22,727 (24,798) (26,478) 72,388 (3,751) 83 177 81 2017

(40,125) (11,380) (25,700) (71,448) (5,000) 65,199 83,900 67 (18,988) 1,849 2,439 633 597 6 1,483 1,705 6 623 365 19 20,200 24,229 (17,810) 25(b) 287,595 154,658 25(b) (175,572) (11,022) 25(b),28 (115,796) 7(a) (16,090) (7,205) 28 (5,469) (7,581) 9(b) (15,350) (8,519) 17(a) (42,488) 721 (83,170) 121,052 13,447 99,491 229,984 132,478 (10,676) (1,985) 25 232,755 229,984 83 177 82

1. 22 (i) (ii) 2. a) 3 83 2017

2. b 2(f) 2(ab) 2(e) 2(aa) 33 84

2. c 2(j)) 85 2017

2. d) 2(j)) 86

2. e) 2(s)(v) (iv) 2(j)) 2(s)(v) 87 2017

2. f) 2(h)) 2(s)(ii) 2(h)) 2(h) g) 2(j)(ii)) 50 5 5 10 10 5 88

2. g) (i) (ii) h 89 2017

2. h i) 2(f)) ii) i) 90

2. j) i) 2(d)) 2(j)(ii) 2(j)(ii) 91 2017

2. j) i) 92

2. j) ii 93 2017

2. j) ii iii 34 2(j)(i) (ii)) k) 2(j)(i)) l) 94

2. m) n) o) 95 2017

2. o) 2(f) 96

2. p) q) r) 97 2017

2. r) s) i ii) iii) iv) v) 98

2. t) u) 99 2017

2. v) i) 12 19 2 5 100

2. v) i) ii) 101 2017

2. v) ii) w) i) ii) 102

2. w) iii 38 103 2017

2. x a) i) ii) iii) b) i) ii iii iv) v) vi) (a) vii) (a)(i) viii 104

2. y) 8 5 z) aa) 39 2(s) 105 2017

2. aa) 39 ab 3. 7 12 12 25 7 106

4. 575,322 643,933 246,803 222,482 209,363 187,112 1,031,488 1,053,527 5. 1. 2. 107 2017

5. a) EBITDA EBITDA EBITDA 108

5. a) 175,205 183,754 736,355 759,165 209,362 187,112 1,120,922 1,130,031 40,815 18,307 16,467 57,282 18,307 216,020 202,061 752,822 759,165 209,362 187,112 1,178,204 1,148,338 EBITDA 31,424 32,928 22,188 24,259 73,990 62,285 127,602 119,472 10 11 276 332 347 188 633 531 10,103 635 10,103 635 311 224 4,346 2,184 21,118 20,657 25,775 23,065 323,249 364,492 825,688 784,642 179,814 204,708 1,328,751 1,353,842 43,067 69,233 43,067 69,233 9,433 34,567 30,209 5,558 2,340 40,125 41,982 25,819 102,076 375,893 351,903 42,236 20,356 443,948 474,335 109 2017

5. b) 1,178,204 1,148,338 (57,282) (18,307) (89,434) (76,504) 4 1,031,488 1,053,527 127,602 119,472 38,311 15,401 (25,775) (23,065) (26,210) (12,969) (30,601) (9,795) 83,327 89,044 110

5. b) 1,328,751 1,353,842 (34,454) (35,219) 1,294,297 1,318,623 14,141 19,401 17,895 17,400 6,065 38,315 1,332,398 1,393,739 443,948 474,335 (24,801) (39,132) 419,147 435,203 10,028 15,503 25,641 28,169 235,947 276,214 690,763 755,089 111 2017

5. c) (i) (ii) 856,283 869,773 382,658 389,883 175,205 183,754 91,887 92,303 1,031,488 1,053,527 474,545 482,186 d) 10% A 104,383 115,099 112

6. 633 597 1,849 2,439 2,764 2,742 2,106 2,070 6,668 14,437 14,020 22,285 1,082 1,368 (447) 8,486 (9,972) (4,071) 13,255 2,739 2,236 1,566 930 (321) 556 38,311 15,401 113 2017

7. a) 16,090 7,205 10,120 5,764 26,210 12,969 b) 101,068 75,410 10,449 8,953 7,172 83 118,689 84,446 c) 20 18,831 18,831 1,435 1,386 409 1,011 22 708,317 729,955 13 5,579 4,234 13 1,365 23(c) (237) 951 4,897 (3,717) 330 248 (1,282) 119 153 7,863 8,435 460,000 313,000 (2,304) (2,429) 12,828 7,813 7,172 83 442 443 (i) 31,170,000 25,182,000 114

8. a) 6,035 7,308 13,288 17,614 29(b) (2,528) (3,284) 16,795 21,638 i) ii) 16.5% iii) 25% 25% 15% 115 2017

8. b) 83,327 89,044 21,615 27,388 16,078 7,492 (23,020) (12,904) (66) (80) (503) (434) 2,740 176 (49) 16,795 21,638 c) 296,857,000 291,366,000 14,843,000 14,568,000 116

9. a 3.43 2.87 2.95 2.64 17,866 16,434 b) 2.95 2.47 1.53 1.37 15,350 8,519 117 2017

10. a) 51,060 46,966 272 51,060 47,238 622,500 622,500 * 28,311 622,500 650,811 * 28 b 118

11. 383(1) 2 1,246 16 256 1,518 1,039 16 231 1,286 853 739 53 231 1,876 156 203 359 156 203 359 156 203 359 468 3,138 739 85 1,327 5,757 1,289 1,289 1,070 1,070 891 494 52 1,437 150 150 158 158 150 150 458 3,250 494 52 4,254 119 2017

11. 12 12. 3 3 11 1,301 1,419 29 29 348 1,678 1,448 1,000,000 2 2 120

13. a b a b 3,838 12,620 12,701 8,611 37,770 37,770 6 4 245 255 255 67 6,553 1,827 1,665 1,268 11,380 11,380 (148) (308) (50) (506) (506) 3,911 19,029 14,220 10,471 1,268 48,899 48,899 3,911 19,029 14,220 10,471 1,268 48,899 48,899 (7) (5) (361) (373) (373) 15 12,618 12,618 62,382 75,000 16 18,988 18,988 12,193 12,193 11,641 111 1,690 4,911 617 8,962 27,932 27,932 8,588 220 (8,808) (393) (185) (150) (728) (728) 24,259 12,603 20,541 18,946 10,577 1,422 88,348 93,563 181,911 3,160 6,643 4,928 7,228 21,959 21,959 6 4 241 251 251 277 2,422 1,134 401 4,234 4,234 (109) (194) (50) (353) (353) 3,443 8,960 5,868 7,820 26,091 26,091 3,443 8,960 5,868 7,820 26,091 26,091 (7) (5) (256) (268) (268) 1,091 995 1,392 1,589 512 5,579 1,365 6,944 (293) (99) (145) (537) (537) 1,091 4,431 10,054 7,358 7,931 30,865 1,365 32,230 23,168 8,172 10,487 11,588 2,646 1,422 57,483 92,198 149,681 468 10,069 8,352 2,651 1,268 22,808 22,808 121 2017

13. (a) (b) 84,185,000 27 14. 107,880 250 108,130 4,470 112,600 a) (i) (ii) b) c) 100,000,000 96,000,000 27) 122

14. d) (i) 13 112,600 112,600 123 2017

14. d) (i) 108,130 108,130 (ii) (i) (ii) 36,712 39,650 37,624 41,701 4.25%-4.50% 4.25%-4.50% 4.25%-4.50% 4.25%-4.50% 100% 100% 124

14. d) (ii) (i) (ii) 108,130 107,880 4,470 250 112,600 108,130 e 1,681 2,386 1,051 332 2,732 2,718 f 125 2017

15. 75,000,000 16. 18,988,000 126

17. BVI 100% 111 1 100% 195,546,680 100% 1 (b)) 100% 180,900,000 (c)) 55% 2,000,000 127 2017

17. a) BVI b) c) d) e) 45% 45% 171,664 199,774 99,204 114,592 (64,152) (45,505) (12,004) (14,788) 194,712 254,073 * 88,541 114,835 209,362 187,112 34,046 45,098 33,267 43,401 * 15,472 20,440 * f g 52,488 721 55,811 10,002 34,394 17,059 (78,675) 2,085 * 51% 128

17. f 41,400 26(d) 10,000 51,400 1,088 721 52,488 721 g) 51,400,000 55% 20,000,000 11,000,000 129 2017

18. 90,693 90,693 90,693 20.70% 17.07% -2% 5% 3% 44.5% 45.0% 130

19. 43,067 69,233 5,000,000 50% a) b 131 2017

19. 67,152 61,885 135,183 119,369 (97,003) (27,586) (19,198) (15,202) 86,134 138,466 9,666 5,656 (1,766) (1,005) (19,198) (15,202) 178,868 153,008 27,668 12,586 27,668 12,586 15,984 (174) (221) 26 19 (8,556) (3,898) 86,134 138,466 50% 50% 43,067 69,233 13,834 6,293 13,834 6,293 40,400 39,600 80,000 20,200 23 19,800 40,000 132

19. 6% 6% 6% 6% 100% 100% 133 2017

20. a b 104,727 28,700 133,427 12,000 5,262 17,262 13,091 5,740 18,831 25,091 11,002 36,093 25,091 11,002 36,093 13,091 5,740 18,831 38,182 16,742 54,924 66,545 11,958 78,503 79,636 17,698 97,334 (a) (b) 23.72% 26.91% 19.43% 19.90% -2% 5% 3% 45.5% 45.0% 134

21. (a) 300 300 (b) 13,841 19,101 14,141 19,401 (c) 25,783 65,199 (a) (b) (i) Sinopharm Healthcare Fund L. P. 3.89% 5,000,000 33,930,000 3.89% 9.99% 1,500,000 10,180,000 1,000,000 6,900,000 535,000 4,897,000 2,069,000 14,900,000 12,400,000 14,300,000 12,800,000 3.89% 9.99% (ii) Dong Hua Tong Investments Limited 15% 1,700,000 1,400,000 7,100,000 6,300,000 (c) 3% 5% 3.5% 3.8% 135 2017

22. 7,113 4,471 5,546 3,422 136,222 119,740 148,881 127,633 708,317 726,859 3,096 708,317 729,955 23. 259,987 295,233 (c) (5,440) (5,677) 254,547 289,556 38,979 43,802 (g) 43,743 48,521 (f) 1,121 36 553 40 19,800 357,622 383,040 22,006 19,672 1,182 1,191 36 32,064 33,971 412,874 437,874 a) 136

23. b) 0 90 225,323 255,667 91 180 12,002 22,692 181 365 17,209 3,788 1 13 7,409 254,547 289,556 30 90 32 c) 5,677 4,726 7(c)) 951 7(c)) (237) 5,440 5,677 5,440,000 5,677,000 5,440,000 5,677,000 137 2017

23. d) 225,323 255,667 91 180 12,002 22,692 181 365 17,209 3,788 13 7,409 29,224 33,889 254,547 289,556 e) 27) 138

23. f) 1,121,000 2,914,000 1,121,000 g) 15 52,300,000 43,700,000 54,200,000 48,500,000 21(b)(ii)) 139 2017

24. (a) 4,775 4,232 (b) 17,895 17,400 (a) 10% 4,800,000 (b) 2,302,000 2.13% 25. 232,487 229,575 268 409 232,755 229,984 a 750 9,297 233,505 239,281 (a) 750,000 9,297,000 26 140

25. (b) 114,909 311,196 426,105 16,090 10,120 26,210 287,595 287,595 (175,572) (175,572) (115,796) (115,796) (16,090) (5,469) (21,559) (3,764) (10,239) (14,003) 412,980 412,980 26. (c)) 126,636 237,446 8,500 10,413 27,174 15,999 (d) 10,000 172,310 263,858 63,743 7,831 6,061 242,114 271,689 (a) (b) 750,000 16,043,000 750,000 9,297,000 141 2017

26. (c) 0 90 125,916 233,757 91 180 720 3,689 126,636 237,446 45 90 d) 27. 1 412,980 311,196 c 362,980 264,341 50,000 46,855 412,980 311,196 a) b) 3.3%-5.66%% 1.8%-5.22% 142

27. c) 14) 100,000 96,000 13 23,168 13 61,017 128,928,000 234,052,000 28. 114,909 133,837,500 105,584,000 Shine Light Investment Fund Legend Times Corporation Limited 105,448,000 7.4% 2.15 62,250,000 13,383,750 10,558,000 143 2017

28. 133,837,500 1) 18 18 2) 5.0% 3) 4) 5% 19,654,000 114,909,000 6,259,000 * 144

28. 4,155 94,905 99,060 (94,905) (94,905) 106,642 6,259 112,901 5,764 5,764 (7,581) (7,581) 5,929 5,929 114,909 6,259 121,168 10,120 10,120 (5,469) (5,469) (3,764) (3,764) (115,796) (115,796) (6,259) (6,259) 12.9% 9.8% 145 2017

29. a) 15,503 17,059 6,035 7,308 13,288 17,614 19,323 24,922 (24,798) (26,478) 10,028 15,503 (316) 823 10,334 14,680 b) 17,425 12,585 172 30,182 1,271 1,271 8(a) (2,824) 18 (478) (3,284) 14,601 12,603 172 793 28,169 14,601 12,603 172 793 28,169 8(a) (2,824) 1,089 (793) (2,528) 11,777 13,692 172 25,641 c) 8(c) 146

30. (a) 533 (b) (c) 13,623 533 13,623 (a) 55% c 32,047,000 35,252,000 38,777,000 3 39 7,177,000 4,604,000 14.71% 533,000 147 2017

30. (b) c Caretalk Technology Co. Ltd Caretalk 55% Caretalk Caretalk Caretalk 55 Caretalk Caretalk 13,255,000 c) 178,335,400 368,000 148

31. a b d e g h i 53,468 152,700 95,863 6,259 (20,476) 753 (19,654) (80,036) 188,877 (30,544) (30,544) 2,873 2,873 2,873 (30,544) (27,671) 28 (6,259) 19,654 (13,395) 7,356 7,356 9 (15,350) (15,350) 53,468 152,700 95,863 (17,603) 8,109 (139,225) 153,212 53,468 152,700 95,863 94,905 (21,271) 210 (50,282) 325,593 (21,235) (21,235) 795 795 795 (21,235) (20,440) 543 543 28 (88,646) (19,654) (108,300) 9 (8,519) (8,519) 53,468 152,700 95,863 6,259 (20,476) 753 (19,654) (80,036) 188,877 149 2017

31. a) 0.1 10,000,000 1,000,000 877,900 0.1 622,500 62,250 53,468 b) c) 10% 50% 25% 150

31. d) e) 28 2(u) f) 2(e) g) 2(r) h) 2(w)(iii) i 151 2017

31. j) i) ii) 109,238,000 168,527,000 3.43 2.87 2.95 2.64 17,866,000 16,434,000 9) k) 412,980 311,196 114,909 412,980 426,105 (233,505) (239,281) 179,475 186,824 641,635 638,650 27.97% 29.25% 152

32. a) i) ii) 30 90 iii) 10.78% 4.34% 31.61% 20.00% 23 iv) v) 153 2017

32. b) 126,636 126,636 126,636 8,500 8,500 8,500 27,174 27,174 27,174 10,000 10,000 10,000 446,942 446,942 412,980 619,252 619,252 585,290 237,446 237,446 237,446 10,413 10,413 10,413 15,999 15,999 15,999 313,696 313,696 311,196 125,554 125,554 114,909 703,108 703,108 689,963 154

32. c) i) % % 3.3%-5.66% 412,980 1.8%-5.22% 311,196 412,980 311,196 100% 100% 750 9,297 232,755 229,984 155 2017

32. c) ii) 100 2,335,000 2,393,000 100 d) 533,000 367,000 156

32. d) i) 62,253 69,647 84 90 4,259 2,952 14,285 41 27,934 25,020 1 (18,026) (6) (80,155) (181,485) (849) 1 (46,855) (103,928) (156,538) 90,187 94,667 84 90 4,259 2,953 14,285 41 (18,026) (46,861) (184,083) (338,023) (849) 157 2017

32. d) ii) 5% 3,608 (5%) (3,608) 5% (9,200) (5%) 9,200 5% 213 (5%) (213) 5% 672 (5%) (672) 5% 2,390 (5%) (2,390) 5% (16,897) (5%) 16,897 5% 148 (5%) (148) (5%) 2 (5%) (2) 158

32. d) ii) e) 44.8% 50.5% 60 f) 13 159 2017

32. f) 13,841 12,460 1,381 19,101 12,761 6,340 25,783 25,783 65,199 65,199 4,775 4,775 4,232 4,232 17,895 17,895 17,400 17,400 533 533 13,623 367 13,256 160

32. f) 1. 3% 5% 3.48% 3.63% 2. 3. 161 2017

32. f) 4,604 (16,362) 1,138 86,296 75,676 64,500 5,000 69,500 (86,296) (86,296) (4,604) 3,106 (768) (2,266) 5,202 699 5,901 (13,256) 6,340 65,199 4,232 62,515 (13,256) 6,340 65,199 4,232 62,515 25,700 25,700 (65,199) (65,199) 13,256 13,256 543 543 (4,959) 83 (4,876) 1,381 25,783 4,775 31,939 162

33. 2 a) b) 163 2017

33. c) d) e) f) g) 164

33. h) i) 90,693,000 90,693,000 18 j) 38 k l) (1) 15% (2) (3) 2,900 165 2017

34. a) 8,866 7,596 16,644 9,670 25,510 17,266 b) 2,525 20,256 Sinopharm Healthcare Fund L.P. 3.89% 21(b)(i) 16,268 10,405 150,000 166

35. 5% 30,000 30,000 10,449,000 8,953,000 36. a) 1) 167 2017

36. b) (i) 9,187 (i) 3,174 12,361 (i) 479 479 (i) 150 150 23 (ii) 2,526 3,008 (ii) 29,538 30,963 32,064 33,971 23 (iii) 1,121 23 (iii) 19 15 (iii) 19 15 (iii) 13 10 (iii) 502 i) ii) iii) 168

36. c) 11 12 7,374 7,409 228 193 2,453 10,055 7,602 37. 38. 169 2017

38. (a) 3,572,000 13,236,000 4 4 300,000 2 6,200,000 3 23,308,000 (b) 2.54 22,840,000 2.54 22,840,000 2.54 (6,491,000) 2.54 16,349,000 2.54 22,840,000 2.54 4,079,000 2.54 300,000 2.54 2.54 1.2 2.3 170

38. (c) 0.770 0.768 0.781 0.782 0.839 0.841 0.768 0.259 0.230 2.450 2.450 2.450 2.450 1.360 2.540 2.540 2.540 2.540 2.540 0.438% 0.657% 0.876% 0.438% 0.606% 63.07% 54.39% 52.13% 63.07% 59.49% 1.89% 2.25% 2.34% 1.89% 2.04% 280% 220% 280% 220% 280% 220% 220% 220% 171 2017

39. 216,957 216,957 502 130 245,923 263,700 6,065 38,183 252,490 302,013 1,894 4,768 80,289 53,086 234,052 156,537 114,909 316,235 329,300 (63,745) (27,287) 153,212 189,670 793 153,212 188,877 53,468 53,468 99,744 135,409 153,212 188,877 172

40. 9 1 15 1 16 4 17 4 22 2 23 2 1 4 4 9 1 9 2 10 3 28 40 1 28 1 28 2 2 1 2 3 4 173 2017

40. 9 9 9 9 a) b) 9 39 9 9 39 174

40. 9 39 9 39 9 9 9 9 9 15 15 15 18 11 15 175 2017

40. 15 15 1 2 3 4 5 15 15 15 16 2(h) 16 16 12 16 16 16 176

40. 22 22 23 23 2 40 40 41. 177 2017

1,031,488 1,053,527 713,548 660,323 554,763 83,327 89,044 51,322 48,667 63,214 (16,795) (21,638) (11,935) (10,802) (16,037) 66,532 67,406 39,387 37,865 47,177 51,060 46,966 31,205 37,865 47,177 1,332,398 1,393,739 1,089,331 1,019,489 730,083 690,763 755,089 402,065 448,514 272,659 553,094 523,815 537,918 570,975 457,424 178